津药药业股份有限公司关于子公司注射用甲泼尼龙琥珀酸钠获得巴拿马共和国卫生部注册证书的公告
Filed with SSE ·
On 6ix: 6ix.com/news/news-15
6ix hasn’t read this filing yet.
Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix
Earlier from Tianjin Tianyao Pharmaceuticals
- Announcement on Subsidiary’s Products Being Proposed for Selection in the National Centralized Drug Procurement
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
- Announcement on the Company's Receipt of the Notice of Approval for Marketing Application of Chemical APIs
- 2025 Semi-annual Report
Later from Tianjin Tianyao Pharmaceuticals
- Announcement on Outline of the Q3 2025 Performance Briefing
- Announcement on Resolutions of the 22nd Meeting of the 9th Board of Directors
- Announcement on Resolutions of the 23rd Meeting of the 9th Board of Directors
- Announcement on Resignation of Senior Management Member
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianjin Tianyao Pharmaceuticals